This invention relates to certain metabolites of N-(1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6-((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide In particular, the present invention relates to pharmaceutical compositions comprising these metabolites, as well as processes for their preparation and their use in the treatment of diseases.
本发明涉及N-(
1-甲基-5-(三
氟甲基)-1H-
吡唑-3-基)-5-((6-((甲
氨基)
甲基)
嘧啶-4-基)
氧基)-1H-
吲哚-1-羧
酰胺的某些代谢物。具体而言,本发明涉及包含这些代谢物的制药组合物,以及它们的制备过程和在治疗疾病中的应用。